CA Stock MarketDetailed Quotes
IPCI.H IntelliPharmaCeutics International Inc
- 0.080
- 0.0000.00%
15min DelayMarket Closed Mar 5 10:01 ET
2.65MMarket Cap-655P/E (TTM)
0.000High0.000Low0Volume0.000Open0.080Pre Close0.00Turnover0.00052wk High0.00%Turnover Ratio33.09MShares0.00052wk Low-0.122EPS TTM2.60MFloat Cap0.000Historical HighLossP/E (Static)32.51MShs Float0.000Historical Low-0.121EPS LYR0.00%Amplitude--Dividend TTM-0.15P/B1Lot Size--Div YieldTTM
IntelliPharmaCeutics International Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | (Q3)Aug 31, 2022 | (Q2)May 31, 2022 | (Q1)Feb 28, 2022 | (FY)Nov 30, 2021 | (Q4)Nov 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 182.15%240.83K | 126.50%89.73K | 97.47%-14.18K | 43.60%-1.39M | 41.65%-195.93K | 78.48%-293.15K | 55.67%-338.57K | -90,080.90%-560.58K | -2,295.50%-2.46M | 45.57%-335.75K |
| Net income from continuing operations | -547.96%-1.89M | 93.56%-54.12K | 59.62%-355.74K | 43.78%-2.89M | 55.05%-879.2K | 76.94%-291.57K | 15.95%-840.65K | 4.72%-880.97K | -51.73%-5.15M | -20.59%-1.96M |
| Operating gains losses | 236.91%7.79K | 97.90%-10.47K | -100.42%-5 | -2,616.09%-50.2K | 27,008.78%453.68K | 43.11%-5.69K | -4,288.65%-499.37K | -32.82%1.18K | -98.09%2K | -102.10%-1.69K |
| Depreciation and amortization | -21.08%40.63K | -21.24%40.55K | -20.86%40.74K | -21.21%206.06K | -21.04%51.62K | -21.26%51.48K | -21.26%51.48K | -21.27%51.48K | -37.04%261.53K | -39.46%65.38K |
| Asset impairment expenditure | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 33.49%627.17K | ---- |
| Remuneration paid in stock | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -83.27%11.99K | --0 |
| Deferred tax | ---- | ---- | ---- | 94.12%-5.52K | ---- | ---- | ---- | ---- | ---93.85K | ---- |
| Other non cashItems | 2,498.20%4.01K | -131.34%-6.68K | 115.35%11.39K | -81.48%83.72K | -90.62%13.49K | -100.09%-167 | -58.98%21.32K | -222.55%-74.21K | -40.91%451.92K | 238.71%143.8K |
| Change In working capital | 4,501.58%2.08M | -87.03%120.46K | -15.35%289.44K | -10.75%1.27M | -80.67%170K | 86.48%-47.2K | 778.60%928.65K | -56.55%341.94K | -15.15%1.42M | 182.09%879.53K |
| -Change in receivables | --333.58K | -426.76%-122.06K | -464.68%-210.93K | -100.08%-602 | -100.28%-602 | --0 | 131.32%37.35K | -106.59%-37.35K | 337.23%780.34K | 274.86%213.96K |
| -Change in prepaid assets | -102.00%-1.21K | -115.74%-6.3K | 81.19%-46.11K | -245.29%-77.82K | -24.44%66.99K | 187.36%60.32K | 1,182.41%40.01K | -751.34%-245.13K | 31.06%53.56K | 891.96%88.66K |
| -Change in payables and accrued expense | 1,524.44%1.53M | -70.77%248.81K | 9.04%546.47K | 128.88%1.35M | -78.08%103.61K | 70.70%-107.52K | 224.61%851.29K | 126.49%501.14K | -70.02%589.19K | -13.70%472.67K |
| -Change in other current liabilities | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 421.53%123.28K | ---- | ---- |
| -Change in other working capital | --213.73K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 182.15%240.83K | 126.50%89.73K | 97.47%-14.18K | 43.60%-1.39M | 41.65%-195.93K | 78.48%-293.15K | 55.67%-338.57K | -90,080.90%-560.58K | -2,295.50%-2.46M | 45.57%-335.75K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 500K | 0 | 0 | 500K | 0 | 0 | ||
| Net PPE purchase and sale | --0 | --0 | ---- | --500K | --0 | --0 | --500K | ---- | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | ---- | --500K | --0 | --0 | --500K | ---- | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -93.40%200K | 3.03M | 0 | |||||||
| Net issuance payments of debt | ---- | ---- | ---- | --200K | ---- | ---- | ---- | ---- | --0 | ---- |
| Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --3.07M | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---38.22K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | ---- | ---- | -93.40%200K | ---- | ---- | ---- | ---- | --3.03M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -57.28%159.27K | -67.10%69.55K | -89.15%83.72K | 282.06%771.95K | -92.81%79.65K | -84.91%372.8K | 4.29%211.36K | 282.06%771.95K | 212.66%202.05K | 38.71%1.11M |
| Current changes in cash | 182.15%240.83K | -44.42%89.73K | 97.47%-14.18K | -220.76%-688.22K | 101.21%4.07K | 78.48%-293.15K | -92.88%161.43K | -90,080.90%-560.58K | 314.70%569.9K | 43.71%-335.75K |
| End cash Position | 402.33%400.1K | -57.28%159.27K | -67.10%69.55K | -89.15%83.72K | -89.15%83.72K | -92.81%79.65K | -84.91%372.8K | 4.29%211.36K | 282.06%771.95K | 282.06%771.95K |
| Free cash from | 182.15%240.83K | 126.50%89.73K | 97.47%-14.18K | 43.60%-1.39M | 41.65%-195.93K | 78.48%-293.15K | 55.67%-338.57K | -90,080.90%-560.58K | -2,374.10%-2.46M | 45.57%-335.75K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data